Ruxolitinib ≥99% (par HPLC)
Marques : Enzo Life SciencesTotal Evaluation: 0
Moyenne des Notes : 0.0 sur 5
JAK inhibitor
Ruxolitinib is a Janus kinase inhibitor with IC50 values of 2.7 and 4.5, respectively, for JAK1 and JAK2.
Formule:
C₁₇H₁₈N₆ |
Numéro MDL:
MFCD12031592 Numéro CAS: 941678-49-5 |
|
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...